Search - tctmd.com

Displaying 1 - 20 of 109

Sort: Relevancy | Date

Presentation TCT 2025

Transcatheter Mitral Valve Repair Using a Leaflet Enhancing Coaptation Device (Polares)

Presenter: Fabio Sandoli de Brito

October 28, 2025

Presentation TCT 2025

Early Feasibility of the DUO™ Tricuspid Coaptation Valve System (CroiValve)

Presenter: James M. McCabe

October 27, 2025

Presentation TCT 2025

TCT 1523: Acute Volume Management With Ipovolemic Phlebotomy to Reduce the Coaptation Gap in T-TEER

Presenter: Nicolò Azzola Guicciardi

October 26, 2025

Presentation TCT 2025

TCT 886: The CoApt Valve: A Novel Atrioventricular Valve Device by NeoCor

Presenter: George A. Kramer

October 26, 2025

Presentation TCT 2025

TCT 222: Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation: Mind the Gap Between Guidelines and COAPT Criteria

Presenter: Philipp von Stein

October 25, 2025

Presentation NY Valves 2025

The CroiValve DUO Novel Tricuspid Coaptation Valve System

Presenter: Wojtek Wojakowski

June 26, 2025

Presentation NY Valves 2025

Design and Development of the CoApt Valve™: A Novel Atrioventricular Valve Device

Presenter: George A. Kramer

June 25, 2025

Presentation NY Valves 2025

Association of Site Volume and MitraClip Outcomes in Secondary Mitral Regurgitation: Insights From the COAPT PAS Registry

Presenter: Kashish Goel

June 25, 2025

Presentation NY Valves 2025

Underutilized – COAPT and RESHAPE-HF2 Are Just the Beginning

Presenter: Ralph Stephan von Bardeleben

June 25, 2025

Presentation TCT 2024

Percutaneous Treatment of Tricuspid Regurgitation with the Novel TriFlO® Device: Technology and Clinical Update

Presenter: Gian Paolo Ussia

October 29, 2024

Presentation TCT 2024

Early Human Results with the Versa Tricuspid Valve Leaflet Extension System

Presenter: Neil Fam

October 29, 2024

Presentation TCT 2024

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Presenter: Stefan Anker

October 27, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique

Presenter: Giulia Passaniti

June 05, 2024

Presentation NY Valves 2024

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Presenter: Guillaume Bonnet

June 05, 2024

Presentation THT Abstracts 2024

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Presenter: Charles Sherrod

March 04, 2024

Presentation Miami Valves 2024

Testing the Limits of TEER Beyond COAPT

Presenter: Diego H. González-Bravo

February 03, 2024

Presentation Miami Valves 2024

Edge to Edge Repair in Severe LV Dilatation (Beyond COAPT)

Presenter: Solomon A. Seifu

February 03, 2024

Presentation TCT 2023

Topic 5: Management of Wide TV Coaptation Gaps

Presenter: Nadira Hamid

October 26, 2023

Advertisement

Transcatheter Mitral Valve Repair Using a Leaflet Enhancing Coaptation Device (Polares)

Early Feasibility of the DUO™ Tricuspid Coaptation Valve System (CroiValve)

TCT 1523: Acute Volume Management With Ipovolemic Phlebotomy to Reduce the Coaptation Gap in T-TEER

TCT 886: The CoApt Valve: A Novel Atrioventricular Valve Device by NeoCor

TCT 222: Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation: Mind the Gap Between Guidelines and COAPT Criteria

The CroiValve DUO Novel Tricuspid Coaptation Valve System

Design and Development of the CoApt Valve™: A Novel Atrioventricular Valve Device

Association of Site Volume and MitraClip Outcomes in Secondary Mitral Regurgitation: Insights From the COAPT PAS Registry

Underutilized – COAPT and RESHAPE-HF2 Are Just the Beginning

Percutaneous Treatment of Tricuspid Regurgitation with the Novel TriFlO® Device: Technology and Clinical Update

Early Human Results with the Versa Tricuspid Valve Leaflet Extension System

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Testing the Limits of TEER Beyond COAPT

Edge to Edge Repair in Severe LV Dilatation (Beyond COAPT)

Topic 5: Management of Wide TV Coaptation Gaps

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content